The DOI matches its Crossref record; 398 of the 398 references it cites were found in a registry or an index.
Pathogenesis of Systemic Sclerosis
Open accessAbstract
Systemic scleroderma (SSc) is one of the most complex systemic autoimmune diseases. It targets the vasculature, connective tissue-producing cells (namely fibroblasts/myofibroblasts), and components of the innate and adaptive immune systems. Clinical and pathologic manifestations of SSc are the result of: (1) innate/adaptive immune system abnormalities leading to production of autoantibodies and cell-mediated autoimmunity, (2) microvascular endothelial cell/small vessel fibroproliferative vasculopathy, and (3) fibroblast dysfunction generating excessive accumulation of collagen and other matrix components in skin and internal organs. All three of these processes interact and affect each other. The disease is heterogeneous in its clinical presentation that likely reflects different genetic or triggering factor (i.e., infection or environmental toxin) influences on the immune system, vasculature, and connective tissue cells. The roles played by other ubiquitous molecular entities (such as lysophospholipids, endocannabinoids, and their diverse receptors and vitamin D) in influencing the immune system, vasculature, and connective tissue cells are just beginning to be realized and studied and may provide insights into new therapeutic approaches to treat SSc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–398 of 398
Postlethwaite, A. E., & Seyer, J. M. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.6.1749 · Cited by 110
Self-citationGourh, P., Agarwal, S. K., Divecha, D., Assassi, S., Paz, G., Arora-Singh, R. K., Reveille, J. D., Shete, S. S., Mayes, M. D., Arnett, F. C., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24958 · Cited by 109
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
Bogatkevich, G. S., Ludwicka, A., & Silver, R. M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24935 · Cited by 108
Davies, C. A., Jeziorska, M., Freemont, A. J., & Herrick, A. L. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.10.007 · Cited by 108
Rueda, B., Gourh, P., Broen, J., Agarwal, S. K., Simeon, C., Ortego-Centeno, N., Vonk, M. C., Coenen, M., Riemekasten, G., Hunzelmann, N., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.118174 · Cited by 108
Rockwell, C. E., & Kaminski, N. E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065524 · Cited by 107
Li, Y., Spataro, B. C., Yang, J., Dai, C., & Liu, Y. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00562.x · Cited by 107
Martín, J., Assassi, S., Díaz-Gallo, L.-M., Broen, J. C. A., Simeón‐Aznar, C. P., Castellvi, I., Vicente‐Rabaneda, E. F., Fonollosa‐Pla, V., Ortego‐Centeno, N., González-Gay, M. Á., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt248 · Cited by 106
The role of CB1 in immune modulation by cannabinoids
Kaplan, B. L. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.004 · Cited by 105
Vitamin D Deficiency and Insufficiency in 2 Independent Cohorts of Patients with Systemic Sclerosis
Vacca, A., Cormier, C., Piras, M., Mathieu, A., Kahan, A., & Allanore, Y. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081287 · Cited by 105
Gourh, P., Tan, F. K., Assassi, S., Ahn, C. W., McNearney, T. A., Fischbach, M., Arnett, F. C., & Mayes, M. D. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22196 · Cited by 104
Martín, J., Broen, J. C. A., Carmona, F. D., Teruel, M., Simeón‐Aznar, C. P., Vonk, M. C., Slot, R. V. ‘., Rodríguez‐Rodríguez, L., Vicente, E. F., Fonollosa‐Pla, V., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds099 · Cited by 104
Autologous stem cell transplantation improves microcirculation in systemic sclerosis
Miniati, I., Guiducci, S., Conforti, M. L., Rogai, V., FIORI, G., Cinelli, M., Saccardi, R., Guidi, S., Bosi, A., Tyndall, A., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.082495 · Cited by 104
Ahmed, S., Tan, F. K., Arnett, F. C., Li, J., & Geng, Y. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21952 · Cited by 102
Mathian, A., Parizot, C., Dorgham, K., Trad, S., Arnaud, L., Larsen, M., Miyara, M., Hié, M., Pietté, J. C., Francès, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200709 · Cited by 102
Circulating miR-142-3p levels in patients with systemic sclerosis
Makino, K., Jinnin, M., Kajihara, I., Honda, N., Sakai, K., Masuguchi, S., Fukushima, S., Inoue, Y., & Ihn, H. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2011.04158.x · Cited by 101
Vitamin D effects on B cell function in autoimmunity
Rolf, L., Muris, A., Hupperts, R., & Damoiseaux, J. G. M. C. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12440 · Cited by 101
Systemic sclerosis: Genetics and epigenetics
Luo, Y., Wang, Y., Wang, Q., Xiao, R., & Lu, Q. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.01.012 · Cited by 101
Rosenbloom, J., Feldman, G., Freundlich, B., & Jimenez, S. A. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290706 · Cited by 101
Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity
Avouac, J., Juin, F., Wipff, J., Couraud, P., Chiocchia, G., Kahan, A., Boileau, C., Uzan, G., & Allanore, Y. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.082131 · Cited by 101
The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
Carmona, F. D., Martín, J., Beretta, L., Simeón‐Aznar, C. P., Carreira, P. E., Callejas-Rubio, J. L., Castro, M. F., Comet, L. S., Beltrán, E., Camps, M. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054419 · Cited by 101
Basu, S., Ray, A., & Dittel, B. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102195 · Cited by 100
The Role of Dendritic Cells in Tissue-Specific Autoimmunity
Mbongue, J. C., Nicholas, D., Firek, A. F., & Langridge, W. H. R. (2014) · Journal of Immunology Research · doi:10.1155/2014/857143 · Cited by 99
Li, Z., & Jiménez, S. A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30317 · Cited by 99
Slobodin, G., Sheikh‐Ahmad, M., Rosner, I., Peri, R., Rozenbaum, M., Kessel, A., Toubi, E., & Odeh, M. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2009.12.009 · Cited by 99
Kong, W., Li, H., Tuma, R. F., & Ganea, D. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.11.002 · Cited by 99
Broen, J. C. A., Bossini‐Castillo, L., van Bon, L. G., Vonk, M. C., Knaapen, H., Beretta, L., Rueda‐Medina, B., Hesselstrand, R., Herrick, A. L., Worthington, J., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33325 · Cited by 99
Wu, S., Leng, L., Feng, Z. Z., Liu, N., Zhao, H., McDonald, C., Lee, A., Arnett, F. C., Gregersen, P. K., Mayes, M. D., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22179 · Cited by 98
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
Martínez‐Pinilla, E., Reyes‐Resina, I., Oñatibia‐Astibia, A., Zamarbide, M., Ricobaraza, A., Navarro, G., Moreno, E., Dopeso‐Reyes, I. G., Sierra, S., Rico, A. J., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.017 · Cited by 95
Dieudé, P., Guedj, M., Wipff, J., Ruiz, B., Riemekasten, G., Airo, P., Melchers, I., HACHULLA, E., Matucci‐Cerinic, M., Diot, É., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131243 · Cited by 95
Very low levels of vitamin D in systemic sclerosis patients
Caramaschi, P., Gassa, A. D., Ruzzenente, O., et al. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1478-3 · Cited by 94
Avouac, J., Fürnrohr, B. G., Tomčík, M., Palumbo, K., Zerr, P., Horn, A., Dees, C., Akhmetshina, A., Beyer, C., Distler, O., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30171 · Cited by 94
Distler, J. H. W., Allanore, Y., Avouac, J., Giacomelli, R., Guiducci, S., Moritz, F., Akhmetshina, A., Walker, U. A., Gabrielli, A., Müller-Ladner, U., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091918 · Cited by 94
Association of the FAM167A-BLK region with systemic sclerosis.
Ito, I., Kawaguchi, Y., Kawasaki, A., Hasegawa, M., Ohashi, J., Kawamoto, M., Fujimoto, M., Takehara, K., Sato, S., Hara, M., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27303 · Cited by 93
Epigenetics, the holy grail in the pathogenesis of systemic sclerosis
Altorok, N., Almeshal, N., Wang, Y., & Kahaleh, B. (2014) · Rheumatology · doi:10.1093/rheumatology/keu155 · Cited by 92
Zhu, S., Evans, S., Yan, B., Povsic, T. J., Tapson, V. F., Goldschmidt‐Clermont, P. J., & Dong, C. (2008) · Circulation · doi:10.1161/circulationaha.108.787200 · Cited by 90
Slominski, A., Janjetovic, Z., Tuckey, R. C., Nguyen, M. N., Bhattacharya, K. G., Wang, J., Li, W., Jiao, Y., Gu, W., Brown, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3074 · Cited by 89
Self-citationMaiti, A. K., Kim-Howard, X., Viswanathan, P., Guillén, L., Rojas‐Villarraga, A., Deshmukh, H., Direskeneli, H., Saruhan‐Direskeneli, G., Cañas, C. A., Tobón, G. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27222 · Cited by 89
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
Díaz-Gallo, L.-M., Gourh, P., Broen, J. C. A., Simeón‐Aznar, C. P., Fonollosa‐Pla, V., Ortego‐Centeno, N., Agarwal, S. K., Vonk, M. C., Coenen, M. J. H., Riemekasten, G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130138 · Cited by 89
Zhou, X., Tan, F. K., Wang, N., Xiong, M., Maghidman, S., Reveille, J. D., Milewicz, D. M., Chakraborty, R., & Arnett, F. C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11220 · Cited by 88
Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis
Liang, Y.-L., Wu, H., Shen, X., Li, P.-Q., Yang, X.-Q., Liang, L., Tian, W.-H., Zhang, L.-F., & Xie, X.-D. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1754-1 · Cited by 88
Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis
Kuwana, M., Kaburaki, J., Okazaki, Y., Yasuoka, H., Kawakami, Y., & Ikeda, Y. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21899 · Cited by 88
Neilson, E. G., Jiménez, S. A., & Phillips, S. M. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1708 · Cited by 87
Involvement of Rho-Kinase in Agonists-Induced Contractions of Arteriosclerotic Human Arteries
Kandabashi, T., Shimokawa, H., Mukai, Y., Matoba, T., Kunihiro, I., Morikawa, K., Ito, M., Takahashi, S., Kaibuchi, K., & Takeshita, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.104274 · Cited by 87
Serum lipids regulate dendritic cell CD1 expression and function
Leslie, D. S., Dascher, C. C., Cembrola, K., Townes, M. A., Hava, D. L., Hugendubler, L., Mueller, E., Fox, L. M., Roura‐Mir, C., Moody, D. B., et al. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02842.x · Cited by 86
Marquart, S., Zerr, P., Akhmetshina, A., Palumbo, K., Reich, N., Tomčík, M., Horn, A., Dees, C., Engel, M., Zwerina, J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27642 · Cited by 85
Kottyan, L. C., Zoller, E. E., Bene, J., Lu, X., Kelly, J. A., Rupert, A., Lessard, C. J., Vaughn, S. E., Marion, M. C., Weirauch, M. T., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu455 · Cited by 85
Fleischmajer, R. (1976) · Archives of Dermatology · doi:10.1001/archderm.112.11.1553 · Cited by 85
Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids
Börner, C., Höllt, V., Sebald, W., & Kraus, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306224 · Cited by 84
Platelet contributions to the pathogenesis of systemic sclerosis
Postlethwaite, A. E., & Chiang, T. M. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282eeb3a4 · Cited by 84
Self-citationGreenblatt, M. B., Sargent, J. L., Farina, G. A., Tsang, K., Lafyatis, R., Glimcher, L. H., Whitfield, M. L., & Aliprantis, A. O. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.024 · Cited by 84
Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β1signalling
Mutlu, G. M., Budinger, G. R. S., Wu, M., Lam, A. P., Zirk, A., Rivera, S., Urich, D., Chiarella, S. E., Go, L. H. T., Ghosh, A. K., et al. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200717 · Cited by 84
Bossini‐Castillo, L., Martín, J., Broen, J. C. A., Gorlova, O. Y., Simeón‐Aznar, C. P., Beretta, L., Vonk, M. C., Callejas-Rubio, J. L., Castellvi, I., Carreira, P. E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr522 · Cited by 83
Mm, G., & Madhok, R. (1996) · PubMed · Cited by 83
Elevated plasma levels of endothelin‐1 in systemic sclerosis
Yamane, K., Kashiwagi, H., Suzuki, N., Miyauchi, T., Yanagisawa, M., Goto, K., & Masaki, Τ. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340220 · Cited by 81
Hattori, N., Mizuno, S., Yoshida, Y., Chin, K., Mishima, M., Sisson, T. H., Simon, R. H., Nakamura, T., & Miyake, M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63196-3 · Cited by 81
Ames, P. R. J., Lupoli, S., Alves, J. D., Atsumi, T., Edwards, C., Iannaccone, L., Khamashta, M. A., Hughes, G. R., & Brancaccio, V. (1997) · Lara D. Veeken · doi:10.1093/rheumatology/36.10.1045 · Cited by 81
Martínez–Godínez, M. D. L. Á., Cruz-Domínguez, M. P., Jara, L. J., Domínguez‐López, A., Luna, R. A. J., Lastra, O. L. V., Montes-Cortes, D. H., Campos‐Rodríguez, R., López-Sánchez, D. M., Mejía-Barradas, C. M., et al. (2015) · PubMed · Cited by 81
Johnson, M. E., Mahoney, J. M., Taroni, J., Sargent, J. L., Marmarelis, E. L., Wu, M.-R., Varga, J., Hinchcliff, M., & Whitfield, M. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0114017 · Cited by 80
Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis
Papp, G., Horvath, I. F., Baráth, S., Gyimesi, E., Sipka, S., Szodoray, P., & Zeher, M. (2011) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2010.528021 · Cited by 80
Bossini‐Castillo, L., Broen, J. C. A., Simeón‐Aznar, C. P., Beretta, L., Vonk, M. C., Ortego‐Centeno, N., Espinosa, G., Carreira, P. E., Camps, M. T., Navarrete‐Navarrete, N., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.141838 · Cited by 80
MicroRNA in immunity and autoimmunity
Zhu, S., Pan, W. Q., & Qian, Y. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1043-z · Cited by 79
Serine proteases, inhibitors and receptors in renal fibrosis
Eddy, A. A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-12-0779 · Cited by 79
PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population
Terao, C., Ohmura, K., Kawaguchi, Y., Nishimoto, T., Kawasaki, A., Takehara, K., Furukawa, H., Kochi, Y., Ota, Y., Ikari, K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37777 · Cited by 77
Wei, J., Bhattacharyya, S., & Varga, J. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833de1a7 · Cited by 77
Circulating V?1 + T cells are activated and accumulate in the skin of systemic sclerosis patients
Giacomelli, R., Matucci‐Cerinic, M., Cipriani, P., Ghersetich, I., Lattanzio, R., Pavan, A., Pignone, A. M., Cagnoni, M. L., Lotti, T., & TONIETTI, G. (1998) · Arthritis & Rheumatism · Cited by 76
Klein, S. M., Kretz, C. C., Ruland, V., Stumpf, C., Haust, M., Hartschuh, W., Hartmann, M., Enk, A., Suri‐Payer, E., Oberle, N., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.116525 · Cited by 76
Zochling, J., Newell, F., Charlesworth, J., Leo, P., Stankovich, J. M., Cortés, A., Zhou, Y., Stevens, W., Sahhar, J., Roddy, J., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0438-8 · Cited by 76
Self-citationArnson, Y., Amital, H., Guiducci, S., et al. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04808.x · Cited by 75
Yasuoka, H., Hsu, E., Ruiz, X. D., Steinman, R. A., Choi, A. M. K., & Feghali-Bostwick, C. A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080991 · Cited by 75
The Pathology of Scleroderma Vascular Disease
Fleming, J. N., & Schwartz, S. M. (2008) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2008.01.001 · Cited by 74
Redistribution of Sphingosine 1-Phosphate by Sphingosine Kinase 2 Contributes to Lymphopenia
Sensken, S.-C., Bode, C., Nagarajan, M., Peest, U., Pabst, O., & Gräler, M. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903358 · Cited by 74
Association of STAT4 polymorphism with systemic sclerosis in a Japanese population
Tsuchiya, N., Kawasaki, A., Hasegawa, M., Fujimoto, M., Takehara, K., Kawaguchi, Y., Kawamoto, M., Hara, M., & Sato, S. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.111310 · Cited by 74
New insight on the Xq28 association with systemic sclerosis
Carmona, F. D., Cénit, M. C., Díaz-Gallo, L.-M., Broen, J. C. A., Simeón‐Aznar, C. P., Carreira, P. E., Callejas-Rubio, J. L., Fonollosa‐Pla, V., López‐Longo, F. J., González-Gay, M. Á., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202742 · Cited by 74
Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus
Marion, T. N., & Postlethwaite, A. E. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0440-x · Cited by 73
Self-citationAntiangiogenic plasma activity in patients with systemic sclerosis
Mulligan‐Kehoe, M. J., Drinane, M. C., Mollmark, J. I., Casciola-Rosen, L. A., Hummers, L. K., Hall, A. E., Rosen, A., Wigley, F. M., & Simons, M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22861 · Cited by 73
Carmona, F. D., Gutala, R. V., Simeón‐Aznar, C. P., Carreira, P. E., Ortego‐Centeno, N., Vicente‐Rabaneda, E. F., Hernández, F. J. G., de la Peña, P. G., Castro, M. F., Martínez‐Estupiñán, L., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200275 · Cited by 73
Anaya, J., Kim-Howard, X., Prahalad, S., Cherñavsky, A. C., Cañas, C. A., Rojas‐Villarraga, A., Bohnsack, J. F., Jonsson, R., Bolstad, A. I., Brun, J. G., et al. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.07.007 · Cited by 72
Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis
Tan, X., Li, Y., & Liu, Y. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.11.011 · Cited by 72
The Fra-2 transgenic mouse model of systemic sclerosis
Maurer, B., Distler, J. H. W., & Distler, O. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2012.12.001 · Cited by 71 · cited 4×
“The Fra-2 TG mice also developed pulmonary vascular lesions resembling SSc-associated PAH and later developed dermal and pulmonary fibrosis resembling the “non-specific interstitial pneumonia” (NSIP) (328).”
BackgroundInfluentialBossini‐Castillo, L., Martín, J., Broen, J. C. A., Simeón‐Aznar, C. P., Beretta, L., Gorlova, O. Y., Vonk, M. C., Ortego‐Centeno, N., Espinosa, G., Carreira, P. E., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201888 · Cited by 71
Induction of fibroblast proliferation by human mononuclear leukocyte‐derived proteins
Postlethwaite, A. E., & Kang, A. H. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780260104 · Cited by 70
Self-citationKoumakis, E., Giraud, M., Dieudé, P., Cohignac, V., Cuomo, G., Airò, P., HACHULLA, E., Matucci‐Cerinic, M., Diot, E., Caramaschi, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34490 · Cited by 70
Dhillon, S., Kaker, A., Dosanjh, A., Japra, D., & VanThiel, D. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1220-7 · Cited by 69
Fang, F., Shangguan, A. J., Kelly, K., Wei, J., Gruner, K., Ye, B., Wang, W., Bhattacharyya, S., Hinchcliff, M., Tourtellotte, W. G., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.06.016 · Cited by 69
Postlethwaite, A. E., Smith, G. N., Lachman, L. B., Endres, R. O., Poppleton, H., Hasty, K. A., Seyer, J. M., & Kang, A. H. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113927 · Cited by 69
Self-citationAgudelo, M., Newton, C. A., Widen, R. H., Sherwood, T. A., Nong, L., Friedman, H. P., & Klein, T. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9088-9 · Cited by 69
Rettori, E., Laurentiis, A. D., Zubilete, M. Z., Rettori, V., & Elverdin, J. C. (2012) · NeuroImmunoModulation · doi:10.1159/000339113 · Cited by 67
Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β
Tanaka, S., Suto, A., Ikeda, K., Sanayama, Y., Nakagomi, D., Iwamoto, T., Suzuki, K., Kambe, N., Matsue, H., Matsumura, R., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/ket254 · Cited by 67
Mackiewicz, Z., Sukura, A., Povilenaité, D., Čeponis, A., Virtanen, I., Hukkanen, M., & Konttinen, Y. T. (2002) · PubMed · Cited by 66
Unraveling the genetic component of systemic sclerosis
Martín, J., Bossini‐Castillo, L., & Martin, J. J. (2012) · Human Genetics · doi:10.1007/s00439-011-1137-z · Cited by 66
Agarwal, S. K., Gourh, P., Shete, S. S., Paz, G., Divecha, D., Reveille, J. D., Assassi, S., Tan, F. K., Mayes, M. D., & Arnett, F. C. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090421 · Cited by 66
Rostkowska-Nadolska, B., Sliupkas-Dyrda, E., Potyka, J., Kuśmierz, D., Frączek, M., Kr̨ecicki, T., Kubik, P., Zatoński, M., & Latocha, M. T. (2010) · Advances in Medical Sciences · doi:10.2478/v10039-010-0012-9 · Cited by 65
Alterations in collagen production in mixed mononuclear leukocyte-fibroblast cultures.
Hibbs, M. S., Postlethwaite, A. E., Mainardi, C. L., Seyer, J. M., & Kang, A. H. (1983) · The Journal of Experimental Medicine · doi:10.1084/jem.157.1.47 · Cited by 65
Self-citationCirculating miR-29a levels in patients with scleroderma spectrum disorder
Kawashita, Y., Jinnin, M., Makino, T., Kajihara, I., Makino, K., Honda, N., Masuguchi, S., Fukushima, S., Inoue, Y., & Ihn, H. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.11.007 · Cited by 65
Carmona, F. D., Serrano, A., Rodríguez‐Rodríguez, L., Castañeda, S., Miranda-Filloy, J. A., Morado, I. C., Narváez, J., Solans, R., SOPEÑA, B., Marí-Alfonso, B., et al. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110685 · Cited by 64
Genetics of Systemic Sclerosis: An Update
Broen, J. C. A., Coenen, M. J. H., & Radstake, T. R. D. J. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-011-0221-7 · Cited by 64
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
Garcia-Gonzalez, E., Selvi, E., Balistreri, E., Lorenzini, S., Maggio, R., Natale, M.-R., Capecchi, P.-L., Lazzerini, P.-E., Bardelli, M., Laghi-Pasini, F., et al. (2009) · Rheumatology · doi:10.1093/rheumatology/kep189 · Cited by 63
Fleming, K. E., & Wanless, I. R. (2013) · Liver International · doi:10.1111/liv.12099 · Cited by 63
Lenna, S., Farina, G. A., Martyanov, V., Christmann, R., Wood, T. A., Farber, H. W., Scorza, R., Whitfield, M. L., Lafyatis, R., & Trojanowska, M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37891 · Cited by 63
microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma
Eto, M., Jinnin, M., Makino, K., Yamane, K., Nakayama, W., Aoi, J., Honda, N., Kajihara, I., Makino, T., Fukushima, S., et al. (2012) · Archives of Dermatological Research · doi:10.1007/s00403-012-1287-4 · Cited by 63
Dieudé, P., Dawidowicz, K., Guedj, M., Legrain, Y., Wipff, J., HACHULLA, E., Diot, É., Sibilia, J., Mouthon, L., Cabané, J., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091163 · Cited by 62
Bu, S., Asano, Y., Bujor, A. M., Highland, K. B., Hant, F. N., & Trojanowska, M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27463 · Cited by 61
Drozdenko, G., Heine, G., & Worm, M. (2013) · Experimental Dermatology · doi:10.1111/exd.12300 · Cited by 61
Dieudé, P., Guedj, M., Truchetet, M., Wipff, J., Revillod, L., Riemekasten, G., Matucci‐Cerinic, M., Melchers, I., HACHULLA, E., Airo, P., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30204 · Cited by 61
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature
MacIntyre, J. N., Dong, A. X., Straiker, A. J., Zhu, J., Howlett, S. E., Bagher, A. M., Denovan‐Wright, E. M., Yu, D., & Kelly, M. E. M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.055 · Cited by 61
Tsuji, S., Kaji, K., & Nagasawa, S. (1994) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124598 · Cited by 61
Penumarti, A., & Abdel‐Rahman, A. A. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209213 · Cited by 61
Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation
Rajesh, M., Mukhopadhyay, P., Haskó, G., & Pacher, P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.159 · Cited by 60
Kajihara, I., Jinnin, M., Yamane, K., Makino, T., Honda, N., Igata, T., Masuguchi, S., Fukushima, S., Okamoto, Y., Hasegawa, M., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.030 · Cited by 58
Update on pathophysiology of scleroderma with special reference to immunoinflammatory events
Chizzolini, C. (2006) · Annals of Medicine · doi:10.1080/07853890601098152 · Cited by 58
Dieudé, P., Boileau, C., Guedj, M., Avouac, J., Ruiz, B., HACHULLA, E., Diot, É., Cracowski, J., TIEV, K. P., Sibilia, J., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.147009 · Cited by 58
Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis
Beretta, L., Rueda‐Medina, B., Marchini, M., Santaniello, A., Simeón‐Aznar, C. P., Fonollosa‐Pla, V., Caronni, M., Ríos-Fernández, R., Carreira, P. E., Rodríguez‐Rodríguez, L., et al. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker335 · Cited by 58
Yin, Z., Tong, Y., Zhu, H., & Watsky, M. A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00291.2007 · Cited by 57
O’Shea, J. J., Notarangelo, L. D., Johnston, J. A., & Candotti, F. (1997) · Journal of Clinical Immunology · doi:10.1023/a:1027388508570 · Cited by 56
Immune system: A possible nexus between cannabinoids and psychosis
Suárez‐Pinilla, P., López-Gil, J., & Crespo‐Facorro, B. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.01.018 · Cited by 56
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
Balistreri, E., Garcia-Gonzalez, E., Selvi, E., Akhmetshina, A., Palumbo, K., Lorenzini, S., Maggio, R., Lucattelli, M., Galeazzi, M., & Distler, J. W. H. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137539 · Cited by 56 · cited 1×
“Subcutaneous inflammatory cell infiltration, dermal thickness, and CI content were comparable to the control group (440).”
BackgroundKawaguchi, Y., McCarthy, S. A., Watkins, S. C., & Wright, T. M. (2004) · PubMed · Cited by 56
Egr-1 Induces a Profibrotic Injury/Repair Gene Program Associated with Systemic Sclerosis
Bhattacharyya, S., Sargent, J. L., Du, P., Lin, S. M., Tourtellotte, W. G., Takehara, K., Whitfield, M. L., & Varga, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023082 · Cited by 55
Coustet, B., Dieudé, P., Guedj, M., Bouaziz, M., Avouac, J., Ruiz, B., HACHULLA, E., Diot, É., Cracowski, J., TIEV, K. P., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30379 · Cited by 54
Serratì, S., Chillà, A., Laurenzana, A., Margheri, F., Giannoni, E., Magnelli, L., Chiarugi, P., Dotor, J., Feijoó, E., Bazzichi, L. M., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37705 · Cited by 54
Kawaguchi, Y., Tochimoto, A., Hara, M., Kawamoto, M., Sugiura, T., Katsumata, Y., Okada, J., Kondo, H., Okubo, M., & Kamatani, N. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1984 · Cited by 54
ELEVATED von WILLEBRAND FACTOR ANTIGEN IN SYSTEMIC SCLEROSIS: RELATIONSHIP TO VISCERAL DISEASE
Greaves, M., Malía, R. G., Ward, A. M., Moult, J., Holt, C. M., Lindsey, N. J., Hughes, P. J., GOODFIEL, M., & Rowell, N. R. (1988) · Lara D. Veeken · doi:10.1093/rheumatology/27.4.281 · Cited by 53
Association of HLA Class II Genes with Systemic Sclerosis in Spanish Patients
Simeón‐Aznar, C. P., Fonollosa‐Pla, V., Tolosa-Vilella, C., Palou, E., Selva-O’Callaghan, A., Solans, R., Armadans, L., Moreno, E., Marsal, S., & Vilardell, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090377 · Cited by 53
Cellular immunity to collagen and laminin in scleroderma
Huffstutter, J. E., Delustro, F. A., & LeRoy, E. C. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280708 · Cited by 52
Hyperplasia of dermal microvascular pericytes in scleroderma*
Helmbold, P., Fiedler, E., Fischer, M. J., & Marsch, W. C. (2004) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2004.00203.x · Cited by 52
Huu, D. L., Matsushita, T., Jin, G., Hamaguchi, Y., Hasegawa, M., Takehara, K., & Fujimoto, M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37933 · Cited by 51
Genetics of scleroderma: implications for personalized medicine?
Assassi, S., Radstake, T. R. D. J., Mayes, M. D., & Martin, J. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-9 · Cited by 51
Innate immunity in systemic sclerosis pathogenesis
O’Reilly, S. (2013) · Clinical Science · doi:10.1042/cs20130367 · Cited by 51
The genetics of systemic sclerosis.
Agarwal, S. K. (2010) · PubMed · Cited by 49
Targeting mediators of vascular injury in scleroderma
Schachna, L., & Wigley, F. M. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200211000-00010 · Cited by 49
Manetti, M., Allanore, Y., Saad, M., Fatini, C., Cohignac, V., Guiducci, S., Romano, E., Airó, P., Caramaschi, P., Tinazzi, I., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200986 · Cited by 49
Ledinek, A. H., Jazbec, S., Drinovec, I., & Rot, U. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509104593 · Cited by 49
Mirko Manetti, A., Allanore, Y., Revillod, L., Fatini, C., Guiducci, S., Cuomo, G., Bonino, C., Riccieri, V., Bazzichi, L. M., Liakouli, V., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30101 · Cited by 48
López‐Isac, E., Bossini‐Castillo, L., Simeón‐Aznar, C. P., Egurbide, M. V., Sancho, J. J. A., Callejas-Rubio, J. L., Román‐Ivorra, J. A., Freire, M., Beretta, L., Santaniello, A., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4432 · Cited by 48
Regulator of G Protein Signaling 5: A New Player in Vascular Remodeling
Manzur, M., & Ganß, R. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.04.002 · Cited by 47
High Rhodotorula Sequences in Skin Transcriptome of Patients with Diffuse Systemic Sclerosis
Arron, S. T., Dimon, M. T., Li, Z.-H., Johnson, M. E., Wood, T. A., Feeney, L., Angeles, J. G. C., Lafyatis, R., & Whitfield, M. L. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.127 · Cited by 47
Fattal, I., Shental, N., Molad, Y., Gabrielli, A., Pokroy‐Shapira, E., Oren, S., Livneh, A., Langevitz, P., Pauzner, R., Sarig, O., et al. (2013) · Immunology · doi:10.1111/imm.12200 · Cited by 47
Vannacci, A., Giannini, L., Passani, M. B., Felice, A. D., Pierpaoli, S., Zagli, G., Fantappiè, O., Mazzanti, R., Masini, E., & Mannaioni, P. F. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068635 · Cited by 47
Manetti, M., Ibba‐Manneschi, L., Fatini, C., Guiducci, S., Cuomo, G., Bonino, C., Bazzichi, L. M., Liakouli, V., Giacomelli, R., Abbate, R., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100237 · Cited by 44
Hamidi, S., Schäfer‐Korting, M., & Weindl, G. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.01.008 · Cited by 44
Raman, P., Kaplan, B. L. F., Thompson, J. T., Heuvel, J. P. V., & Kaminski, N. E. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070441 · Cited by 44
Kozłowska, H., Baranowska, M., Schlicker, E., Kozłowski, M., Laudanski, J., & Malinowska, B. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.371 · Cited by 42
Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis
Tang, L., Chen, B., Ma, B., & Nie, S. (2014) · Genetics and Molecular Research · doi:10.4238/2014.june.16.6 · Cited by 42
Lu, T., Newton, C. A., Perkins, I., Friedman, H. P., & Klein, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.040 · Cited by 41
Cheng, Y., Makarova, N., Tsukahara, R., Guo, H., Shuyu, E., Farrar, P. L., Balázs, L., Zhang, C., & Tigyi, G. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.08.003 · Cited by 41
Effectiveness of etanercept in bleomycin-induced experimental scleroderma
Koca, S. S., Isik, A., Özercan, İ. H., Üstündağ, B., Evren, B., & Metin, K. (2007) · Rheumatology · doi:10.1093/rheumatology/kem344 · Cited by 41
Coustet, B., Bouaziz, M., Dieudé, P., Guedj, M., Bossini-Castillo, L., Agarwal, S., Radstake, T., Martín, J., Gourh, P., Elhai, M., et al. (2012) · Journal of Rheumatology · doi:10.3899/jrheum.111270 · Cited by 41
Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
Díaz-Gallo, L.-M., Simeón‐Aznar, C. P., Broen, J. C. A., Ortego‐Centeno, N., Beretta, L., Vonk, M. C., Carreira, P. E., Vargas, S., Román-Ivorra, J. A., González-Gay, M. Á., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202357 · Cited by 41
Role of T Cells and Cytokines in Effecting Fibrosis
Postlethwaite, A. E. (1995) · International Reviews of Immunology · doi:10.3109/08830189509056716 · Cited by 40
Self-citationUmehara, H., Kumagai, S., Murakami, M., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330619 · Cited by 40
Palumbo‐Zerr, K., Horn, A., Distler, A., Zerr, P., Dees, C., Beyer, C., Selvi, E., Cravatt, B. F., Distler, O., Schett, G. A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201823 · Cited by 40
The genetics of scleroderma: looking into the postgenomic era
Mayes, M. D. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328358575b · Cited by 39
Mair, K., Robinson, E., Kane, K., Pyne, S., Brett, R. R., Pyne, N. J., & Kennedy, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00878.x · Cited by 38
Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis
Mallano, T., Palumbo‐Zerr, K., Zerr, P., Ramming, A., Zeller, B., Beyer, C., Dees, C., Huang, J., Hai, T., Distler, O., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206214 · Cited by 38
Postlethwaite, A. E., Raghow, R., Stricklin, G. P., Ballou, L. R., & Sampath, T. K. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610320 · Cited by 38
Self-citationBossini‐Castillo, L., Simeón‐Aznar, C. P., Beretta, L., Broen, J. C. A., Vonk, M. C., Ríos-Fernández, R., Espinosa, G., Carreira, P. E., Camps, M. T., Castillo, M. J., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3809 · Cited by 38
Yoshizaki, A., Yanaba, K., Ogawa, A., Iwata, Y., Ogawa, F., Takenaka, M., Shimizu, K., Asano, Y., Kadono, T., & Sato, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30470 · Cited by 37
Assessment of vascular involvement.
Kahaleh, B., Meyer, O., & Scorza, R. (2003) · PubMed · Cited by 37
Kanangat, S., Postlethwaite, A. E., Higgins, G. C., & Hasty, K. A. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700097 · Cited by 36 · cited 1×
“When icIL-1ra is overexpressed in cultures in normal human skin fibroblasts via transfection with a viral vector (pLXSNicIL-1ra type 1), it induces a myofibroblast phenotype characterized by increased expression of αSMA and PAI-1 (362).”
BackgroundSelf-citationLupus risk variants in the PXK locus alter B-cell receptor internalization
Vaughn, S. E., Foley, C. L., Lu, X., Patel, Z. H., Zoller, E. E., Magnusen, A. F., Williams, A. H., Ziegler, J. T., Comeau, M. E., Marion, M. C., et al. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2014.00450 · Cited by 36
Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis
Goodfield, M. J. D., Orchard, M. A., & Rowell, N. R. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03145.x · Cited by 36
Martinelli, A., Knapp, S., Anstee, Q. M., Worku, M., Tommasi, A. M., Zucoloto, S., Goldin, R. D., & Thursz, M. R. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05220.x · Cited by 36
Rueda‐Medina, B., Broen, J. C. A., Torres, O., Simeón‐Aznar, C. P., Ortego‐Centeno, N., Schrijvenaars, M. M. V. A. P., Vonk, M. C., Fonollosa‐Pla, V., van den Hoogen, F. H. J., Coenen, M. J. H., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096719 · Cited by 36
Jiménez, S. A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-eular.6222 · Cited by 35
Hair mi R ‐29a levels are decreased in patients with scleroderma
Takemoto, R., Jinnin, M., Wang, Z., et al. (2013) · Experimental Dermatology · doi:10.1111/exd.12245 · Cited by 34
Bossini‐Castillo, L., Simeón‐Aznar, C. P., Beretta, L., Vonk, M. C., Callejas-Rubio, J. L., Espinosa, G., Carreira, P. E., Camps, M. T., Rodríguez‐Rodríguez, L., Rodríguez‐Carballeira, M., et al. (2011) · Rheumatology · doi:10.1093/rheumatology/ker259 · Cited by 33
Characterization of guinea pig lymphocyte-derived chemotactic factor for fibroblasts.
Postlethwaite, A. E., & Kang, A. H. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.3.1462 · Cited by 30
Self-citationPattanaik, D., & Postlethwaite, A. E. (2010) · PubMed · Cited by 29
Self-citationRole of Endoglin in Fibrosis and Scleroderma
Maring, J. A., Trojanowska, M. E., & ten Dijke, P. (2012) · International review of cytology · doi:10.1016/b978-0-12-394308-8.00008-x · Cited by 28
Higgins, G. C., Wu, Y., & Postlethwaite, A. E. (1999) · PubMed · Cited by 28
Self-citationMorimoto, S., Imanaka, S., Koh, E., Shiraishi, T., Nabata, T., Kitano, S., Miyashita, Y., Nishii, Y., & Ogihara, T. (1989) · PubMed · Cited by 28
Analysis of protease‐activated receptor‐1 and ‐2 in human scar formation
Materazzi, S., Pellerito, S., Serio, C. D., Paglierani, M., Naldini, A., Ardinghi, C., Carraro, F., Geppetti, P., Cirino, G., Santucci, M., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2197 · Cited by 27
Martin, J.-E., Carmona, F. D., Broen, J. C. A., Simeón‐Aznar, C. P., Vonk, M. C., Carreira, P. E., Ríos-Fernández, R., Espinosa, G., Vicente‐Rabaneda, E. F., Tolosa-Vilella, C., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.72 · Cited by 26
Koli, K., & Keski‐Oja, J. (1996) · PubMed · Cited by 26
Higgins, G. C., Wu, Y., & Postlethwaite, A. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3969 · Cited by 26
Self-citationCharacterisation of the immune response to type I collagen in scleroderma
Warrington, K. J., Nair, U., Carbone, L. D., Kang, A. H., & Postlethwaite, A. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2025 · Cited by 25
Self-citationComparing HLA Shared Epitopes in French Caucasian Patients with Scleroderma
Azzouz, D. F., Rak, J. M., Fajardy, I., Allanore, Y., TIEV, K. P., Farge, D., Martin, M., Kanaan, S. B., Pagni, P. P., HACHULLA, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036870 · Cited by 25
Pharmacotherapy of systemic sclerosis
Postlethwaite, A. E., Harris, L. J., Raza, S. H., Kodura, S., & Akhigbe, T. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003592177 · Cited by 25
Self-citationHu, P. Q., Oppenheim, J. J., Medsger, T. A., & Wright, T. M. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.03.004 · Cited by 24
Serum levels of interleukin‐1α in patients with systemic sclerosis
Maekawa, T., Jinnin, M., Ohtsuki, M., & Ihn, H. (2012) · The Journal of Dermatology · doi:10.1111/1346-8138.12011 · Cited by 24
Anderson, M., MOORE, T. L., Hollis, S., Clark, S., Jayson, M. I. V., & Herrick, A. L. (2003) · PubMed · Cited by 23
miRT: A Database of Validated Transcription Start Sites of Human MicroRNAs
Bhattacharyya, M., Das, M., & Bandyopadhyay, S. (2012) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2012.08.005 · Cited by 23
Szabó, Á., Czirják, L., Zoltán, S., Helyes, Z., László, T., Elekes, K., Czömpöly, T., Starr, A., Brain, S. D., Szolcsányi, J., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23168 · Cited by 22
Microchimerism and scleroderma
Nelson, J. L. (1999) · Current Rheumatology Reports · doi:10.1007/s11926-999-0019-z · Cited by 21
Cheng, Y., Wang, Y., Li, Y., Deng, Y., Hu, J., Mo, X., Li, N., Li, Y., Luo, N., Yuan, W., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.161 · Cited by 21
Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts
Yin, Z., Carbone, L. D., Gotoh, M., Postlethwaite, A. E., Bolen, A. L., Tigyi, G., Murakami‐Murofushi, K., & Watsky, M. A. (2010) · Rheumatology · doi:10.1093/rheumatology/keq260 · Cited by 21
Self-citationDawidowicz, K., Dieudé, P., Avouac, J., Wipff, J., HACHULLA, E., Diot, É., TIEV, K. P., Cracowski, J., Mouthon, L., Amoura, Z., et al. (2011) · PubMed · Cited by 19
Fine points in mapping autoimmunity
Polychronakos, C. (2011) · Nature Genetics · doi:10.1038/ng.1015 · Cited by 18
Endothelin receptor selectivity: evidence fromin vitroand pre‐clinical models of scleroderma
Shiwen, X., Leask, A., Abraham, D., & Fonseca, C. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02117.x · Cited by 18
Kawashima, T., Yamazaki, R., Matsuzawa, Y., Yamaura, E., Takabatake, M., Otake, S., Ikawa, Y., Nakamura, H., Fujino, H., & Murayama, T. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.038 · Cited by 14
Cutaneous vitamin D3 formation in progressive systemic sclerosis.
Matsuoka, L. Y., Dannenberg, M., Wortsman, J., Bw, H., Jiménez, S. A., & Varga, J. (1991) · PubMed · Cited by 13
Bossini‐Castillo, L., Simeón‐Aznar, C. P., Beretta, L., Broen, J. C. A., Vonk, M. C., Callejas-Rubio, J. L., Carreira, P. E., Rodríguez‐Rodríguez, L., García-Portales, R., González-Gay, M. Á., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4124 · Cited by 12
Autopsy case of systemic sclerosis with severe pulmonary hypertension
Nagai, Y., Yamanaka, M., Hashimoto, C., Nakano, A., Hasegawa, A., Tanaka, Y., Yokoo, H., Nakazato, Y., & Ishikawa, O. (2007) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2007.00381.x · Cited by 11
The expression profile of the toll-like receptor family in scleroderma dermal fibroblasts.
Sakoguchi, A., Nakayama, W., Jinnin, M., Wang, Z., Yamane, K., Aoi, J., Makino, K., Kajihara, I., Ichihara, A., Makino, T., et al. (2014) · PubMed · Cited by 11
Wang, J. C. C. (2009) · Acta Haematologica · doi:10.1159/000204591 · Cited by 7
Chiang, T. M., & Postlethwaite, A. E. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.04.003 · Cited by 7
Self-citationGenetics of Systemic Sclerosis
Tsuchiya, N., & Kawasaki, A. (2016) · Springer eBooks · doi:10.1007/978-4-431-55708-1_5 · Cited by 6
Cited by
Cottin, V., Hirani, N. A., Hotchkin, D. L., Nambiar, A. M., Ogura, T., Otaola, M., Skowasch, D., Park, J. S., Poonyagariyagorn, H. K., Wuyts, W., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0076-2018 · Cited by 652
Niclosamide: Beyond an antihelminthic drug
Chen, W., Mook, R. A., Premont, R. T., & Wang, J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2017.04.001 · Cited by 444
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Hoffmann-Vold, A.-M., Fretheim, H., Halse, A.-K., Seip, M., Bitter, H., Wallenius, M., Garen, T., Salberg, A., Brunborg, C., Midtvedt, Ø., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0486oc · Cited by 257
Mendoza, F. A., Piera‐Velazquez, S., Farber, J. L., Feghali‐Bostwick, C., & Jiménez, S. A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39421 · Cited by 121
Ma, J., liu, J., Gao, D., Li, X., Zhang, Q., Lv, L., Wang, Y., Li, J., Zhu, Y., Wu, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202104192 · Cited by 53
Metadata
- Authors
- Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2015-06-08
- Volume
- 6
- Pages
- 272-272
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W1505701939
- Cited by
- 405
- References
- 398
- FWCI
- 23.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.